Novonesis stock gains as company commits 4.5 billion DKK to new India enzyme plant
Published on 09/02/2026 at 15:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novonesis stock (ISIN DK0060336014) is trading close to its recent highs, with a quotation of 394.1 DKK as of August 31, 2026 on Nasdaq Copenhagen, and is now backed by a fresh investment decision to build a next generation enzyme production facility in India valued at 4.5 billion DKK according to recent Danish media coverage dated September 2, 2026.
India investment underpins growth strategy
According to a report summarizing Novonesis' latest announcement on September 2, 2026, the company plans to invest about 4.5 billion DKK in expanding its enzyme production site in Patalganga, India, adding a new state of the art facility dedicated to next generation industrial enzymes and strengthening its manufacturing footprint in Asia.
A related corporate communication highlighted that the planned India site expansion is intended to support long term demand growth for enzymes used in sectors such as food, detergents and bioenergy, providing Novonesis with additional capacity to serve both global and regional customers as the company pursues its growth strategy.
Stock trades near 52 week high after Q2 figures
A recent overview from ad hoc news dated September 1, 2026 noted that Novonesis stock was priced at 394.1 DKK as of August 31, 2026 on Nasdaq Copenhagen, representing a 1.81 percent gain over the prior trading day and placing the share close to its 52 week high, with a market capitalization of about 121.21 billion DKK at that date according to the same report.
The same overview stated that the 394.1 DKK price level as of August 31, 2026 was very near the top of Novonesis' trading range over the past year, indicating that the stock has benefited from investor confidence in the company after the publication of strong recent quarterly figures and now trades close to a 52 week peak.
More background on Novonesis stock
Further insights, corporate news and regulatory filings for Novonesis are available in the dedicated ISIN overview.
Enzyme solutions support global industries
Novonesis is known for its portfolio of industrial enzyme solutions that help customers in sectors such as food and beverages, household care, agriculture and bioenergy improve efficiency and sustainability, and the planned India facility is expected to supply next generation enzymes tailored to these applications.
Novonesis stock near recent highs
With Novonesis stock at 394.1 DKK as of August 31, 2026 on Nasdaq Copenhagen and a reported 1.81 percent increase over the prior trading day, the share price remains close to its recent peak in the 52 week range, underlining the company's strong position in the European biotechnology and industrial enzymes market.
Novonesis stock key data
- Company: Novonesis A/S
- ISIN: DK0060336014
- Ticker: NSIS_B
- Trading venue: Nasdaq Copenhagen
- Price (as of August 31, 2026): 394.1 DKK
- Market capitalization: 121.21 billion DKK (as of August 31, 2026)
- Sector / Industry: Biotechnology / Industrial enzymes
- Index membership: not specified
